Medicinal and Synthetic Chemistry

SYNthesis focuses on the Hit to Lead and Lead Optimisation phases of drug discovery. With a large chemistry resource and a creative medicinal chemistry team we see the early stages of the drug discovery process as the area in which we can deliver most value to our clients.

SYNthesis scientists are aware of the trust involved in disclosing internal IP and in the generation of new IP for a client. Client intellectual property is treated with the upmost care. Dissemination of the data is provided on a need to know basis and is controlled in full by the client. Segregated laboratories are also available for large projects.